D-0680-2026 Class II Ongoing

Recalled by Bell Pharmaceuticals, Inc — Belle Plaine, MN

FDA drug recall D-0680-2026 was initiated by Bell Pharmaceuticals, Inc on Jun 25, 2026 and is designated Class II. Reason for recall: SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%). The recall status is ongoing. Affected quantity: 15, 843 units.

Recall details

Product Type
Drugs
Report Date
Jul 22, 2026
Initiation Date
Jun 25, 2026
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
15, 843 units

Product description

QC Quality Choice, Carbamide Peroxide, 6.5%, 0.5 FL. OZ. (15 mL) a) Washer Bulb included (NDC 63868-026-15); b) 1 bottle (NDC 63868-027-16), Distributed by C.D.M.A., Inc., 43157 W. Nine Mile, Novi, MI 48376.

Reason for recall

SubPotent Drug: low pH and significantly reduced assay (~0.6% vs expected ~6 7%).

Distribution pattern

U.S Nationwide

Code information

Lot: a) 1505121, 1505342, exp 2027-04; b) 1505381, exp 2027-04.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0680-2026
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0680-2026. Report a data issue: hello@regdatalab.com.